NCT02716376View on ClinicalTrials.gov

Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
Otitis Media With EffusionChronic Otitis MediaHearing Loss
Interventions
DEVICE

Otovent®

Otovent® is a special designed balloon that is blown up through the nose, also referred to as auto-inflation of the eustachian tube. The patients use the Otovent® 5 times a day.

All Listed Sponsors
lead

Zealand University Hospital

OTHER

NCT02716376 - Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy | Biotech Hunter | Biotech Hunter